{ "slug": "schizophrenia-first-episode", "question": "What is the lifetime risk of experiencing a first psychotic episode or schizophrenia?", "category": "health", "tags": [ "mental-health" ], "no_reliable_estimate": false, "perceived": { "description": "Most people carry a vague sense that schizophrenia is rare, severe, and happens to other people — the kind of illness they associate with news stories about violence or homelessness, not with anyone in their social circle. The folk estimate tends to land somewhere around \"very unlikely,\" which is directionally correct for narrow-definition schizophrenia (~0.5- 0.7%) but underestimates the broader category of psychotic experiences, which epidemiological surveys place at 3-5% lifetime. The stigma attached to psychosis suppresses disclosure, reinforcing the perception that it is rarer than it actually is.\n", "kind": "intuition" }, "native": { "display": "~0.5-0.7% lifetime prevalence of schizophrenia in the general population", "numerator": 7, "denominator": 1000, "unit": "lifetime", "population": "general adult population" }, "normalized": { "lifetime_us_adult": 0.007, "display": "~1 in 143 lifetime (US adult)", "log_value": -2.15, "assumptions": "The 2026 systematic review and meta-analysis in Molecular Psychiatry (Jongsma et al.) reports a pooled lifetime prevalence of 0.62% (95% CI: 0.51%-0.76%) across 60 general-population studies in 24 countries. NIMH cites an international prevalence range of 0.33%-0.75% for schizophrenia among non-institutionalised persons, noting that institutionalised and homeless populations are under-counted in household surveys. The 0.7% (1 in 143) point estimate used here sits at the upper end of the NIMH range and within the confidence interval of the meta-analysis, reflecting the likelihood that true prevalence exceeds household-survey estimates because of under-enumeration of affected individuals in institutional settings, shelters, and on the streets. This is a lifetime prevalence figure, not an annual rate compounded — schizophrenia onset is heavily concentrated in adolescence through the early thirties, making annual compounding inappropriate. Uncertainty band: low 0.004 anchors to NIMH's 0.33% floor for non-institutionalised populations; high 0.012 reflects a plausible ceiling once the systematically excluded institutionalised, incarcerated, and homeless populations are accounted for.\n", "uncertainty": { "low": 0.004, "high": 0.012 }, "scope": "us_adult_lifetime" }, "sources": [ { "url": "https://www.nimh.nih.gov/health/statistics/schizophrenia", "title": "Schizophrenia — Statistics", "publisher": "National Institute of Mental Health (NIMH)", "source_type": "govt_report", "statistic": "The international prevalence of schizophrenia among non-institutionalized persons is 0.33% to 0.75%", "excerpt": "\"Precise prevalence estimates of schizophrenia are difficult to obtain due to clinical and methodological factors such as the complexity of schizophrenia diagnosis, its overlap with other disorders, and varying methods for determining diagnoses. The international prevalence of schizophrenia among non-institutionalized persons is 0.33% to 0.75%. Individuals with schizophrenia and other psychotic disorders may be under-counted in prevalence estimation studies.\"\n", "source_date": "2024-04-01", "source_accessed": "2026-04-24", "archive_url": "http://web.archive.org/web/20260411094957/https://www.nimh.nih.gov/health/statistics/schizophrenia", "calculation_notes": "NIMH provides the 0.33%-0.75% range for non-institutionalised persons, explicitly noting under-counting of institutionalised and homeless individuals. This establishes the floor for the true US prevalence. The estimated average potential life lost of 28.5 years for individuals with schizophrenia in the US contextualises the severity. Used here as the authoritative US-government source anchoring the lower bound.\n" }, { "url": "https://www.nature.com/articles/s41380-026-03533-3", "title": "Global lifetime prevalence of schizophrenia: A systematic review and meta-analysis", "publisher": "Molecular Psychiatry / Nature", "source_type": "peer_reviewed", "statistic": "Pooled lifetime prevalence of schizophrenia in the general population: 0.62% (95% CI: 0.51%-0.76%)", "excerpt": "\"The lifetime prevalence of schizophrenia is 0.62% (95% CI [0.51%–0.76%]) in the general population. Asia has the lowest lifetime prevalence of schizophrenia in the general population, at 0.47% (95% CI [0.35%–0.64%]). Schizophrenia is more prevalent in special populations than in the general population.\"\n", "source_date": "2026-03-01", "source_accessed": "2026-04-24", "archive_url": "http://web.archive.org/web/20260505062513/https://www.nature.com/articles/s41380-026-03533-3", "calculation_notes": "This 2026 meta-analysis is the most comprehensive pooled estimate available, drawing on 60 general-population studies across 24 countries with a combined sample of over 20 million individuals. The 0.62% central estimate and 0.51%-0.76% confidence interval provide the statistical backbone for the normalized figure. The point estimate of 0.7% used for lifetime_us_adult sits at the upper edge of this CI, justified by NIMH's observation that US household surveys under-count institutionalised and homeless individuals with schizophrenia.\n", "independence_note": "Methodologically independent of NIMH's range: the meta-analysis pools primary epidemiological studies worldwide using a systematic search protocol, whereas NIMH's figure synthesises US-focused surveillance and review literature.\n" } ], "comparison_anchors": [ { "label": "Lifetime major depression (US adult)", "lifetime_us_adult": 0.208 }, { "label": "Lifetime bipolar disorder (US adult)", "lifetime_us_adult": 0.028 }, { "label": "Lifetime any psychotic experience (general population)", "lifetime_us_adult": 0.05 } ], "short_label": "Schizophrenia", "myth_framing": "calibrated", "outcome_severity": "serious_harm", "exposure_pattern": "acute", "outcome_type": "mental_trauma", "valence": "negative", "caveats": "The 0.7% figure covers schizophrenia specifically, not all psychotic disorders. Broader definitions that include schizoaffective disorder, brief psychotic episodes, and substance-induced psychosis push the lifetime rate of any psychotic experience to 3-5%. The normalised figure uses a lifetime prevalence, not an annual rate compounded over 59 years, because schizophrenia onset is concentrated in a narrow age window (late teens to early thirties) and recurrence is not well-modelled by independent annual draws. Household surveys systematically under-count affected individuals who are institutionalised, incarcerated, or homeless, so the true prevalence almost certainly exceeds the survey-derived estimates. Risk is not uniformly distributed: urban birth, migration, cannabis use during adolescence, and family history each elevate individual risk substantially. The 28.5-year average life-years-lost figure cited by NIMH reflects both the severity of the condition and the downstream effects on physical health, social integration, and access to care.\n", "quality_score": { "d1": 4, "d2": 5, "d3": 4, "d4": 5, "d5": 5, "d6": 5, "d7": 4, "d8": 5, "avg": 4.625, "scored_by": "extracted-from-transcript", "scored_at": "2026-05-16", "methodology_version": "1.0" }, "reviewer": "8d-eval-2026-05-16", "last_reviewed": "2026-05-16", "reviewed": true, "generated_at": "2026-04-24", "image": { "alt": "A flat vector illustration of an abstract silhouette with fragmented geometric shapes suggesting disrupted perception, in muted tones." }, "attribution": "Likelier — https://likelier.app", "license": "https://creativecommons.org/licenses/by-sa/4.0/", "support": "https://buymeacoffee.com/kgluszczyk?via=likelier&utm_content=api-fear-single", "canonical_url": "https://likelier.app/schizophrenia-first-episode" }